Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations.

MLA

Rejeski, Kai, et al. “Immune Effector Cell-Associated Hematotoxicity: EHA/EBMT Consensus Grading and Best Practice Recommendations.” Blood, vol. 142, no. 10, Sept. 2023, pp. 865–77. EBSCOhost, https://doi.org/10.1182/blood.2023020578.

APA

Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A., Barba, P., Bruno, B., Benjamin, R., Carrabba, M. G., Chabannon, C., Ciceri, F., Corradini, P., Delgado, J., Di Blasi, R., Greco, R., Houot, R., Iacoboni, G., Jäger, U., Kersten, M. J., … Yakoub-Agha, I. (2023). Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations. Blood, 142(10), 865–877. https://doi.org/10.1182/blood.2023020578

Chicago

Rejeski, Kai, Marion Subklewe, Mahmoud Aljurf, Emmanuel Bachy, Adriana Balduzzi, Pere Barba, Benedetto Bruno, et al. 2023. “Immune Effector Cell-Associated Hematotoxicity: EHA/EBMT Consensus Grading and Best Practice Recommendations.” Blood 142 (10): 865–77. doi:10.1182/blood.2023020578.